Program
SR750 tablet
Its studies are mostly in Trigeminal Neuralgia, led by Shanghai SIMR Biotechnology.
Furthest: phase 2, since Aug 22, 20244 company-led studies, 0 open or running
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Shanghai SIMR Biotechnology | 40 open or running | phase 2since Aug 22, 2024 | Sep 27, 2021 | none ahead |
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Sep 27, 2021First study: phase 1 study in Healthy VolunteersFirst studyNCT05083468 · 83 enrolled · Australia
- Feb 20, 2023Phase 1 study in HealthyNCT05753033 · 56 enrolled · China
- Aug 22, 2024Phase 2 study in Trigeminal NeuralgiaNCT06571448 · 138 enrolled · China
- Apr 10, 2025Phase 1 study in HealthyNCT06932536 · 40 enrolled · China
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 4 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT06932536Healthy · China | 1 | Completed | Jul 7, 2025 | 40 |
| NCT06571448Trigeminal Neuralgia · China | 2 | Completed | Jan 26, 2026 | 138 |
| NCT05753033Healthy · China | 1 | Completed | Sep 6, 2023 | 56 |
| NCT05083468Healthy Volunteers · Australia | 1 | Completed | Oct 14, 2022 | 83 |
How it is read
Names in the registry
- “SR750 tablet”, 5 entries
Conditions, from the studies’ own filings
- Trigeminal Neuralgia, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.